Oregon

Oregon has emerged as a premier life sciences hub in the Pacific Northwest, distinguished by a rapidly expanding biotechnology and pharmaceutical sector that generated over $11.5 billion in economic activity in 2023.

The state is globally recognized for its leadership in precision medicine and oncology research, anchored by the world-class Oregon Health & Science University (OHSU) and its Knight Cancer Institute.

Oregon's medical device industry is equally robust, specializing in cardiovascular implants, medical microelectronics and advanced surgical instruments produced by regional leaders like BIOTRONIK and Acumed.

The ecosystem thrives on a strong translational research pipeline, where academic breakthroughs at the University of Oregon and Oregon State University are seamlessly commercialized through dedicated biotech incubators like OTRADI.

In the healthcare innovation space, Oregon is a pioneer in digital health and AI-driven drug discovery, with startups leveraging machine learning to accelerate clinical trials and biomarker identification.

The state's biomanufacturing capabilities are also scaling rapidly, particularly in the Bend-Redmond corridor, which has become a global center for drug delivery technologies and contract development and manufacturing organizations (CDMOs).

Oregon's commitment to sustainable biotechnology and genomic analysis further diversifies its portfolio, attracting significant venture capital and federal NIH funding.

This collaborative environment, supported by the Oregon Bioscience Association, ensures a resilient life sciences workforce and a steady stream of FDA-approved therapeutics and diagnostics.

As the region moves toward 2026, it continues to define the future of personalized healthcare and medical technology on a global scale.